1q5k

From Proteopedia

(Difference between revisions)
Jump to: navigation, search
(New page: 200px<br /> <applet load="1q5k" size="450" color="white" frame="true" align="right" spinBox="true" caption="1q5k, resolution 1.94&Aring;" /> '''crystal structure o...)
Line 1: Line 1:
-
[[Image:1q5k.gif|left|200px]]<br />
+
[[Image:1q5k.gif|left|200px]]<br /><applet load="1q5k" size="350" color="white" frame="true" align="right" spinBox="true"
-
<applet load="1q5k" size="450" color="white" frame="true" align="right" spinBox="true"
+
caption="1q5k, resolution 1.94&Aring;" />
caption="1q5k, resolution 1.94&Aring;" />
'''crystal structure of Glycogen synthase kinase 3 in complexed with inhibitor'''<br />
'''crystal structure of Glycogen synthase kinase 3 in complexed with inhibitor'''<br />
==Overview==
==Overview==
-
Glycogen synthase kinase 3 (GSK3) is a serine/threonine kinase that has, been implicated in pathological conditions such as diabetes and, Alzheimer's disease. We report the characterization of a GSK3 inhibitor, AR-A014418, which inhibits GSK3 (IC50 = 104 +/- 27 nM), in an, ATP-competitive manner (Ki = 38 nM). AR-A014418 does not significantly, inhibit cdk2 or cdk5 (IC50 &gt; 100 microM) or 26 other kinases demonstrating, high specificity for GSK3. We report the co-crystallization of AR-A014418, with the GSK3beta protein and provide a description of the interactions, within the ATP pocket, as well as an understanding of the structural basis, for the selectivity of AR-A014418. AR-A014418 inhibits tau phosphorylation, at a GSK3-specific site (Ser-396) in cells stably expressing human, four-repeat tau protein. AR-A014418 protects N2A neuroblastoma cells, against cell death mediated by inhibition of the phosphatidylinositol, 3-kinase/protein kinase B survival pathway. Furthermore, AR-A014418, inhibits neurodegeneration mediated by beta-amyloid peptide in hippocampal, slices. AR-A014418 may thus have important applications as a tool to, elucidate the role of GSK3 in cellular signaling and possibly in, Alzheimer's disease. AR-A014418 is the first compound of a family of, specific inhibitors of GSK3 that does not significantly inhibit closely, related kinases such as cdk2 or cdk5.
+
Glycogen synthase kinase 3 (GSK3) is a serine/threonine kinase that has been implicated in pathological conditions such as diabetes and Alzheimer's disease. We report the characterization of a GSK3 inhibitor, AR-A014418, which inhibits GSK3 (IC50 = 104 +/- 27 nM), in an ATP-competitive manner (Ki = 38 nM). AR-A014418 does not significantly inhibit cdk2 or cdk5 (IC50 &gt; 100 microM) or 26 other kinases demonstrating high specificity for GSK3. We report the co-crystallization of AR-A014418 with the GSK3beta protein and provide a description of the interactions within the ATP pocket, as well as an understanding of the structural basis for the selectivity of AR-A014418. AR-A014418 inhibits tau phosphorylation at a GSK3-specific site (Ser-396) in cells stably expressing human four-repeat tau protein. AR-A014418 protects N2A neuroblastoma cells against cell death mediated by inhibition of the phosphatidylinositol 3-kinase/protein kinase B survival pathway. Furthermore, AR-A014418 inhibits neurodegeneration mediated by beta-amyloid peptide in hippocampal slices. AR-A014418 may thus have important applications as a tool to elucidate the role of GSK3 in cellular signaling and possibly in Alzheimer's disease. AR-A014418 is the first compound of a family of specific inhibitors of GSK3 that does not significantly inhibit closely related kinases such as cdk2 or cdk5.
==About this Structure==
==About this Structure==
-
1Q5K is a [http://en.wikipedia.org/wiki/Single_protein Single protein] structure of sequence from [http://en.wikipedia.org/wiki/Homo_sapiens Homo sapiens] with TMU as [http://en.wikipedia.org/wiki/ligand ligand]. Active as [http://en.wikipedia.org/wiki/Non-specific_serine/threonine_protein_kinase Non-specific serine/threonine protein kinase], with EC number [http://www.brenda-enzymes.info/php/result_flat.php4?ecno=2.7.11.1 2.7.11.1] Full crystallographic information is available from [http://ispc.weizmann.ac.il/oca-bin/ocashort?id=1Q5K OCA].
+
1Q5K is a [http://en.wikipedia.org/wiki/Single_protein Single protein] structure of sequence from [http://en.wikipedia.org/wiki/Homo_sapiens Homo sapiens] with <scene name='pdbligand=TMU:'>TMU</scene> as [http://en.wikipedia.org/wiki/ligand ligand]. Active as [http://en.wikipedia.org/wiki/Non-specific_serine/threonine_protein_kinase Non-specific serine/threonine protein kinase], with EC number [http://www.brenda-enzymes.info/php/result_flat.php4?ecno=2.7.11.1 2.7.11.1] Full crystallographic information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id=1Q5K OCA].
==Reference==
==Reference==
Line 24: Line 23:
[[Category: Hernandez, F.]]
[[Category: Hernandez, F.]]
[[Category: Jerning, E.]]
[[Category: Jerning, E.]]
-
[[Category: Lucas, J.J.]]
+
[[Category: Lucas, J J.]]
-
[[Category: Markgren, P.O.]]
+
[[Category: Markgren, P O.]]
[[Category: Nilsson, Y.]]
[[Category: Nilsson, Y.]]
[[Category: Nylof, M.]]
[[Category: Nylof, M.]]
[[Category: Ormo, M.]]
[[Category: Ormo, M.]]
-
[[Category: Radesater, A.C.]]
+
[[Category: Radesater, A C.]]
[[Category: Xue, Y.]]
[[Category: Xue, Y.]]
[[Category: TMU]]
[[Category: TMU]]
[[Category: kinase-inhibitor complex]]
[[Category: kinase-inhibitor complex]]
-
''Page seeded by [http://ispc.weizmann.ac.il/oca OCA ] on Mon Nov 12 18:50:40 2007''
+
''Page seeded by [http://oca.weizmann.ac.il/oca OCA ] on Thu Feb 21 14:36:05 2008''

Revision as of 12:36, 21 February 2008


1q5k, resolution 1.94Å

Drag the structure with the mouse to rotate

crystal structure of Glycogen synthase kinase 3 in complexed with inhibitor

Overview

Glycogen synthase kinase 3 (GSK3) is a serine/threonine kinase that has been implicated in pathological conditions such as diabetes and Alzheimer's disease. We report the characterization of a GSK3 inhibitor, AR-A014418, which inhibits GSK3 (IC50 = 104 +/- 27 nM), in an ATP-competitive manner (Ki = 38 nM). AR-A014418 does not significantly inhibit cdk2 or cdk5 (IC50 > 100 microM) or 26 other kinases demonstrating high specificity for GSK3. We report the co-crystallization of AR-A014418 with the GSK3beta protein and provide a description of the interactions within the ATP pocket, as well as an understanding of the structural basis for the selectivity of AR-A014418. AR-A014418 inhibits tau phosphorylation at a GSK3-specific site (Ser-396) in cells stably expressing human four-repeat tau protein. AR-A014418 protects N2A neuroblastoma cells against cell death mediated by inhibition of the phosphatidylinositol 3-kinase/protein kinase B survival pathway. Furthermore, AR-A014418 inhibits neurodegeneration mediated by beta-amyloid peptide in hippocampal slices. AR-A014418 may thus have important applications as a tool to elucidate the role of GSK3 in cellular signaling and possibly in Alzheimer's disease. AR-A014418 is the first compound of a family of specific inhibitors of GSK3 that does not significantly inhibit closely related kinases such as cdk2 or cdk5.

About this Structure

1Q5K is a Single protein structure of sequence from Homo sapiens with as ligand. Active as Non-specific serine/threonine protein kinase, with EC number 2.7.11.1 Full crystallographic information is available from OCA.

Reference

Structural insights and biological effects of glycogen synthase kinase 3-specific inhibitor AR-A014418., Bhat R, Xue Y, Berg S, Hellberg S, Ormo M, Nilsson Y, Radesater AC, Jerning E, Markgren PO, Borgegard T, Nylof M, Gimenez-Cassina A, Hernandez F, Lucas JJ, Diaz-Nido J, Avila J, J Biol Chem. 2003 Nov 14;278(46):45937-45. Epub 2003 Aug 19. PMID:12928438

Page seeded by OCA on Thu Feb 21 14:36:05 2008

Proteopedia Page Contributors and Editors (what is this?)

OCA

Personal tools